Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers
Authors:
- 1 February 2008
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 5 (2) , 78-89
Abstract
Many cancer treatments induce gonadal failure, which can seriously influence the quality of life of survivors by causing infertility and, in women, menopausal symptoms. The authors of this Review discuss the published literature on treatment-induced gonadal failure with the goal of providing practical information on its management for healthcare providers. Many cancer treatments induce gonadal failure, which can cause infertility and menopausal symptoms in women. Improvements in treatments for hematologic malignancies have extended survival, thus making treatment-induced gonadal failure (TIGF) a more widespread problem. We reviewed the published literature on TIGF with the goal of providing practical information for health-care providers engaged in the management of hematologic malignancies. We conclude that managing TIGF involves risk assessment, provision of information, discussion of potential options for preserving fertility, and referral to appropriate specialists. All patients with hematologic malignancies should be given information regarding TIGF at the earliest possible time, ideally before treatment begins.Keywords
This publication has 97 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Female Survivors of Childhood Cancer: Preterm Birth and Low Birth Weight Among Their ChildrenJNCI: Journal of the National Cancer Institute, 2006
- Imminent ovarian failure in childhood cancer survivorsEuropean Journal of Cancer, 2006
- Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimensFertility and Sterility, 2004
- Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignanciesBone Marrow Transplantation, 2001
- Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorderMedical Hypotheses, 1993
- Semen analysis in Hodgkin's disease before the onset of treatmentCancer, 1986
- Gonadal function in men treated for acute leukaemia.BMJ, 1983
- LATE EFFECTS ON GONADAL FUNCTION OF CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND MARROW TRANSPLANTATIONTransplantation, 1983
- Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's diseaseCancer, 1983